Cynthia L Lucchese, Director, on May 07, 2026, executed a purchase for 125,000 shares in Mobia Medical (MOBI) for $1,875,000. Following the Form 4 filing with the SEC, Lucchese has control over a total of 125,000 common shares of the company, with 125,000 shares held directly.
SEC Filing:
William T Harrington, 10% Owner, Director, on January 30, 2026, executed a purchase for 533,333 shares in Mobia Medical (MOBI) for $7,999,995. Following the Form 4 filing with the SEC, Harrington has control over a total of 1,404,183 common shares of the company, with 1,404,183 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1489993/000162828026033811/xslF345X05/wk-form4_1778549813.xml
Sanjay Gajendra, Director, President and Chief Operating Officer, on May 07, 2026, sold 49,361 shares in Astera Labs (ALAB) for $9,833,295. Following the Form 4 filing with the SEC, Gajendra has control over a total of 2,186,301 common shares of the company, with 1,531,301 shares held directly and 655,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1736297/000199817926000013/xslF345X05/wk-form4_1778549820.xml
Keith A. Meister, 10% Owner, Director, on May 07, 2026, executed a purchase for 1,205,147 shares in Genedx Holdings (WGS) for $46,806,729. Following the Form 4 filing with the SEC, Meister has control over a total of 4,786,570 Class A common shares of the company, with 20,129 shares held directly and 4,766,441 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1818331/000101143826000276/xslF345X05/form4.xml